Backgrounds/Aims: A wide range of surgical approaches has been described for hepatic hydatidosis aiming primarily at the reduction of disease recurrence and minimization of postoperative morbidity. 
INTRODUCTION

Hydatidosis is a zoonotic disease caused by Echinococcus
species (E.granulosus, multilocularis, and oligarthus). Cystic echinococcosis (CE) is caused by E. granulosus and alveolar echinococcal disease (AED) by E. multilocularis.
Both the CE and AED involve mainly liver, constituting approximately 75% and 90% of the disease burden, respectively. 1, 2 CE largely remains asymptomatic and is usually detected incidentally. Symptoms appear mainly because of the larger lesion size or its complications (rupture/suppuration). 3 AED also remains indolent and asymptomatic during the incubation period of 5-15 years. AED also masquerades as malignancy due to its infiltrative nature. The clinical presentation may be attributed to its infiltrative nature, manifesting as painful abdomen (30%) or cholestatic jaundice (30%). However, one-third of all cases are detected incidentally. 4 Imaging by ultrasonography (USG) and contrast-enhanced computed tomography (CECT) facilitates diagnosis, staging and classification, and surgical planning of both CE and AED. 5, 6 The treatment of liver hydatids ranges from medical management to liver transplantation in AED. Medical management is associated with a high degree of failure and disease recurrence (20-40%). 7 Similarly, the reported incidence of recurrence and morbidity following conservative surgery in CE is 3-30% and 21%-80%, respectively. 7, 8 Radical surgery increases the operative risk but lowers the likelihood of recurrence in CE. Advances in hepatic resection over the last few decades have increased the safety of major hepatic resection. Currently, hepatic resection remains the mainstay of treatment with a high success rate in CE. [9] [10] [11] Similarly, in the absence of adequate surgical treatment, mortality is close to 90% in AED. 4 Surgical resection is the only optimal treatment available for AED because of its infiltrative nature and metastatic potential. 12 Surgical resections include multi-visceral resection and liver transplantation accompanied with or without visceral and vascular resection and reconstruction.
In this study, we report the spectrum of surgical interventions used to manage liver hydatid disease and their outcomes.
MATERIALS AND METHODS
This study is a retrospective review of a prospectively maintained database of patients with hydatid liver disease (CE and AED) presented or referred to our institute from Surgical protocol (Fig. 1 ) Surgical approach algorithms for CE and AED are depicted in Fig. 1 .
In general, complete surgical resection was the preferred treatment option at our institution. Four types of surgical approaches were followed in CE in the order of preference. Anatomical resection was usually performed for a recurrent and complicated cyst or multiple cysts localized to one lobe of the liver provided that the future liver remnant was adequate. Follow-up The patients were followed up after surgery at monthly intervals for 3 months, and later every 3 to 6 months for 3 years, and then annually. At follow-up, routine blood investigations including hydatid serology (when recurrence was suspected) and imaging by USG or CT were conducted. Disease recurrence was defined on the basis of evidence of 1 or more novel hydatid cysts on imaging.
Statistical analysis
Data were presented as mean±standard deviation (SD)
for continuous variables. Continuous variables were analyzed using independent Student's t-test. A two-tailed pvalue of ＜0.05 was considered statistically significant.
All statistical data were generated using SPSS 20
(Chicago, IL, USA). (Fig. 3) . The mean operative duration and intraoperative blood loss for patients undergoing LDLT was 636.7±20.8 minutes and 1400±346.4 mL, respectively. All the patients underwent right lobe graft with a graft-recipient weight ratio (GRWR) of ＞1 in two patients and 0.81 in one patient. Two patients required vena cava replacement.
End-to-end porto-portal anastomosis (recipient main portal vein to the graft right portal vein interposition extension graft was required in two patients), and arterio-arterial anastomoses (recipient right hepatic artery to graft right hepatic artery) were performed. Duct-to-duct biliary anastomosis was performed in all three cases. The mean hospital stay was 11.3±1.2 days.
The fourth patient had a mass involving right lobe extending to segment 4, involving right hepatic artery, diaphragm, and colon (Fig. 4) . The liver remnant was adequate (40%) and resection was deemed feasible and safe.
Right trisectionectomy, segmental colectomy, partial right diaphragmatic excision with Rouxen Y hepaticojejunostomy, and mesh repair of the diaphragm were performed. 
Morbidity and outcomes
On the Clavien-Dindo scale, 3 patients had grade I, 7
patients had grade II, and 3 patients had grade III complications ( Table 2) 
DISCUSSION
This study addresses the surgical management of hepatic hydatidosis at a tertiary care center, where the maximum disease burden is in the form of recurrent or complicated disease. Thirty-six percent of our patients had recurrent disease.
Medical management alone in CE yielded a success rate of only 10%-30%, failure and recurrence rates of 20%-40% and 3%-30%, 7, 8, 14 respectively.
Surgical excision of cysts can be curative for CE.
Despite the availability of surgical procedures controversy about the most optimal procedure still remains. 3, 15, 16 Conservative procedures are safe and less complex than radical surgery, however, the advantage is offset by postoperative complications of 6-47%. 11, 17 Non-comparative retrospective studies established the safety and effectiveness of radical surgery. A comparative retrospective study by Aydin et al. 17 of 242 patients, reported significantly higher morbidity and recurrence rates with conservative surgery (11% vs. 3%; 24% vs. 3%). Similar results were shown by Tagliacozzo et al. 18 in the study that included 454 patients. Yuksel et al. 19 have compared radical surgery versus conservative surgery. In this randomized study comprising 32 patients, radical surgery scored over conservative surgery both in terms of recurrence (p= 0.04) and complications (p=0.01). The overall recurrence rates following radical surgery range from 0% to 4.65% in contrast to 4.65% to 25% following conservative approach.
20,21
The choice of surgical technique and the radical procedure involved is influenced by size, site, type of the cyst, complications, relation to bile ducts and blood vessels, clinical presentation and surgical expertise. 9, 10 In general, surgical excision was the preferred treatment option at our institution. Conservative surgery was considered when the entire burden of hepatic cysts could not be safely excised.
In our series, 76% of CE patients underwent radical surgery. History of previous surgery and presence of adhesions increases the complexity of the surgery. We found that patients who underwent recurrent CE manifested significantly greater intraoperative blood loss and endured longer operation compared with de-novo CE. No mortality was seen, and the overall morbidity was 52%. However, Clavien-Dindo grade 3 or higher complications were 12%, which is comparable to the current rates reported in the literature. 7, 19 The use of a minimally invasive approach for managing liver hydatid cysts was first documented in 1992. 22 The increased risk of cyst content spillage, and difficulty in aspirating cysts with viscous contents cannot be overlooked. 25 No randomized study has evaluated a minimally invasive approach for the treatment of liver hydatid cyst.
Most published studies are non-comparative observational studies stating the safety of laparoscopic approach with objectively low conversion rates and no mortality. 26 Our series comprised 4 patients who underwent a minimally invasive approach (2 laparoscopic and 2 robotic), without any conversion. However, a single patient had recurrence following laparoscopic partial cystectomy.
AED is slow growing and detected late in the course of disease. 4 It is potentially fatal with a mortality rate exceeding 90% at 10 years if left untreated. Treatment options in AED include radical surgery, interventional procedures, long-term chemotherapy, and finally liver transplantation. 4 The resectability rate is only 25%-40% and generally depends on the stage of the disease, age, patient's general condition, and surgical experience. 27 At our institute, the feasibility of resection was assessed in all patients and considered when single lobe, adequate remnant, and inflow to remnant were involved. LDLT was considered in a patient with total inflow involvement, diffuse bilobar disease, secondary biliary cirrhosis or recurrence of AED post resection precluding further safe resection.
The infiltrative nature of the alveolar disease, associated inflammation, late detection and involvement of surrounding structures such as diaphragm, colon, and major vessels increases the complexity of the surgery.
Multivisceral resection may be indicated more often than not involving diaphragm and colon. Both recipient hepatectomy and implantation is technically more challenging.
Bresson-Hadni et al. 28 had reported a perioperative mortality rate as high as 26%. The dissection around the cava and porta is much more difficult compared with the usual cirrhotic patients. Many cases warrant venacaval replacement. The hilar structure may be too short and require portal vein, and hepatic artery extension via interposition grafts, and bilioenteric anastomosis for biliary reconstruction. 29 In our series, two patients required IVC replacement and portal vein extension grafts. However, no need for such extension was observed in arterial reconstruction and all three patients underwent duct-to-duct biliary anastomoses. Liver transplantation has been performed in AED since the 1980s and the outcome has been good with 5-year actuarial survival close to 70% and recurrence-free survival of 58%. 30 All three patients in our series are surviving with good graft function at a follow-up of 34±4.6 months.
The main limitation of our study relates to the fewer patients investigated. However, the study goal was to highlight disease management in the present era, with too many paradigm shifts pertaining to the safety of liver resections, parenchymal preservation, feasibility and applicability of minimal access surgery.
In summary, hepatic hydatidosis is a disease with variable presentation requiring tailored surgical approaches, for 
